1

Technological Advancements in Newborn Screening (NBS): Leveraging Genetic Sequencing for Early Identification of Lysosomal Storage Disorders (2025–2032)

News Discuss 
The global Gaucher Disease Market is a specialized yet high-value segment of the orphan drug industry. Gaucher disease is a rare, autosomal recessive genetic disorder caused by a deficiency in the enzyme glucocerebrosidase. This deficiency leads to the harmful accumulation of fatty substances (glucocerebrosides) in the liver, spleen, bone marrow, and sometimes the nervous system. https://in.linkedin.com/company/data-bridge-market-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story